Page 4 - Bellevue Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bellevue group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bellevue Group Today - Breaking & Trending Today

Bellevue Group AG Has $95.75 Million Holdings in MacroGenics, Inc. (NASDAQ:MGNX)

Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […] ....

United States , Jeffrey Stuart Peters , Stifel Nicolaus , Macrogenics Inc , Sherbrooke Park Advisers , Bellevue Group , China Universal Asset Management Co , Holdings Channel , Jump Financial , Free Report , Universal Asset Management , Park Advisers , Stuart Peters , Get Free Report , Visit Holdingschannel , Macrogenics Daily ,

Bellevue Group AG Boosts Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […] ....

Jack Anders , Raymond James , Jeff Cislini , Piper Sandler , Bellevue Group , Revolution Medicines Inc , Exchange Commission , Securities Exchange Commission , Bain Capital Life Sciences Investors , Rafferty Asset Management , Investment Management , Revolution Medicines , Free Report , Fire Capital , Point Capital , Capital Life Sciences Investors , Asset Management , Medicines Stock Down , Get Free Report , General Counsel Jeff Cislini , Visit Holdingschannel , Revolution Medicines Daily ,

Bellevue Group AG Has $23.99 Million Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)

Bellevue Group AG grew its holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,535,839 shares of the company’s stock after buying an additional 400,000 shares during the quarter. Bellevue […] ....

Bellevue Group , Citigroup Inc , Jump Financial , Cornercap Investment Counsel Inc , Algert Global , Diamond Therapeutics Inc , Black Diamond Therapeutics , Free Report , Fire Capital , Cornercap Investment Counsel , Diamond Therapeutics , Get Free Report , Black Diamond Therapeutics Daily ,